St. Jude Medical is announcing FDA approval of two of its latest devices, a pacemaker and an AICD, that feature company’s wireless reporting technology. The units can relay status and any unusual events to a physician via the company’s Merlin.net network.
The Accent and Anthem product family features RF telemetry that enables secure, wireless communication between the implanted device and the programmer used by the clinician or a home monitor, making it the first integrated system of pacing devices with wireless telemetry from implant through follow-up. Wireless communication is used when clinicians implant the device and during follow-up appointments, which can be performed in the clinic or via remote monitoring from the patient’s home.
Patient device follow-up can be scheduled to take place automatically, in a hands free manner, with no patient interaction required. Information from the device is then captured by the Merlin@home® transmitter, and becomes available for viewing by the clinician via Merlin.net PCN. In addition to fast access to device data, Merlin.net PCN also allows physicians to compile a more complete patient record, by easily transferring cardiac device data into electronic health records (EHRs).
The Accent RF pacemaker and Anthem RF CRT-P have several features that simplify patient management. These features include AT/AF Alerts, AutoCapture® Pacing System technology that measures the heart’s reaction to pacing beat-by-beat, and the VIP® algorithm that enables the heart’s intrinsic rhythm to prevail when appropriate, thereby reducing unnecessary ventricular pacing.
Press release that features links to product pages: St. Jude Medical Announces FDA Approval of Accent RF and Anthem RF Pacemakers Equipped With Wireless Technology…
Previously: Two Wireless Telemetry Cardiac Pacers Get EU OK; Merlin.net Going Live in Europe; St. Jude’s Merlin.net System Gets an Update; St. Jude Introduces Merlin@home Transmitter for Monitoring of Implanted Cardiac Devices; SJM Gets FDA OK for New AICDs